Growth Kinetics of Genetically Engineered E. Colidh5 Cells in Artificial Cell Apa Membrane Microcapsules: Preliminary Report

References

• , These should be typed single-spaced with one space between each reference. They should be referred to in the text and numbered consecutively in brackets. The full references should contain: Author's name, with surname first, title of the paper, name of the journal (Chemical Abstracts Abbreviations), volume, first and last pages, and year (in parentheses).
   Google Scholar
• Chang, T.M.S. Semipermeable microcapsules. Science 1964; 146524425.
   Google Scholar
• Chang, T.M.S. Hemoglobin corpasules. Research Report for Honours Physiology, Medical Library, McGill University 1957. Also reprinted as part of "30 anniversary in Artificial Red Blood Cells Research 'I J. Biomaterials, Artificial Cells & Artificial Organs 16: 1-9, 1988.
   Google Scholar
• Chang, T.M.S. Artificial Cells. In: Dulbecco, R., ed. Encyclopedia of Human Biology. San Diego: Academic Press, 1997; 1 :457-463.
   Google Scholar
• Chang, T.M.S. Semipermeable aqueous microcapsules ("artificial cells"): with emphasis on experiments in an extracorporeal shunt system.Trans Am SOC Artif Intern Organs1966;12:1319.
   Google Scholar
• Chang, T.M.S., MacIntosh, F.C., Mason, S.G. Semipermeable aqueous microcapsules: I. Preparation and properties. Can. J. Physiol. Pharmacol.,1966;44:115128.
   Google Scholar
• Chang, T.M.S., MacIntosh, F.C., Mason, S.G. Encapsulated hydrophilic compositions and methods of making them. Canadian Patent, 873,815,1971.
   Google Scholar
• Chang, T.M.S. Artificial Cells. Springfie1d:C.C. Thomas Publisher, 1972.
   Google Scholar
• Chang, T.M.S. Artificial Cell including blood substitutes andbiomicroencapsulation: fiom ideas to applications. Artificial Cells, Blood Substitutes and Immbolization Biotechnology, an international journal 22: viixiv,1994
   Google Scholar
• Chang, T.M.S. Recent advances in artificial cells with emphasis on biotechnological and medical approaches based on microencapsulation. Chapter in"Microcapsules and Nanoparticles in Medicine and Pharmacology 'I (ed. Donbrow M), CRC Press, USA, 1992; pp. 323339.
   Google Scholar
• Chang, T.M.S. Artificial cells with emphasis on bioencapsuolation in biotechnology. Biotechnology Annual Review. 1995.
   Google Scholar
• Chang, T.M.S. Microencapsulated adsorbent hemoperfusion for uremia, intoxication and hepatic failure. Kidney Int.7:S387-S392, 1975.
   Google Scholar
• Chang, T.M.S. Biodegradable semipermeable microcapsules containing enzymes, hormones,vaccines, and other biologicals. J Bioengineering 1976;1:2532.
   Google Scholar
• Mathiowitz, E., Langer, R. "Polyanhydride microspheres as drug delivery systems I' fiom"Microcapsu1es and Nanoparticles in Medicine and Pharmacology 'I (ed. Donbrow M). CRC Press, Boca Raton, USA, 1992, pp. 99123.
   Google Scholar
• Chang, T.M.S., Coffey, J.F., Barre, P., Gonda, A., Dirks, J.H., Levy, M.,Lister, C. Microcapsule artificial kidney: treatment of patients with acute drug intoxication. Can. Med. Assoc. J. 1973;108:429433.
   Google Scholar
• Lim, F., Sun, A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science,1980;210:908909.
   Google Scholar
• Goosen MFA, OShea GM, GharapetianHM, Chou S, Sun AM. Optimization of microencapsulation parameters: Semipermeable microcapsules as a bioartificial pancreas. Biotechnol. Bioeng., 198527: 14650.
   Google Scholar
• Chang T.M.S., Wong H. A novel method for cell encapsulation. Patent U.S.A. 1991.
   Google Scholar
• SoonShiong P, Otterlie M, SkjakBraek G, Smidsrod 0, Heintz R, Lama Rp, Espevik T. An immunologic basis for the fibrotic reaction to implanted microcapsules. Transpl. P. 1991;23:75859.
   Google Scholar
• Prakash S and Chang, T..M.S. Genetically engineered E. coli cells containing K. aerogenes gene, microencapsulated in artificial cells for urea and ammonia removal. Biomaterials, Artificial Cells and Immobilization Biotechnology, an international journal. 21:629-636, 1993.
   Google Scholar
• Prakash, S. , Chang, T.M.S. Kinetic studies of microecnapsulated genetically engineered E.coli cells containing K. erogenous gene for urea and ammonia removal. Biotechnology & Bioengineering 1995,635-641.
   Google Scholar
• Chang, T..M.S. and Prakash, S. (1996). Artificial cells for bioencapsulation of cells and genetically engineered E. coli : for cell therapy, genetherapy and removal of urea and ammonia. Chapter 23 in book on "Expression and Detection of Recombinant Genes" in Methods in Molecular Biology series.
   Google Scholar
• Prakash, S. and Chang, T.M.S. (1996). Microencapsulated genetically engineered E.coli DH5 cells for plasma urea and ammonia removal based on: 1.column bioreactor and 2. oral administration in uremic rats. Artificial Cells, Blood Substitutes & Immobilizatio Biotechnology, an international journal. 24:20 1-2 1 8.
   Google Scholar
• Prakash, S. and Chang, T.M.S.( 1996). Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats" Nature Medicine. 2: 883-887, August 1996.
   Google Scholar
• Chang, T.M.S. and Prakash, S. (1998). Therapeutic uses of microencapsulated genetically engineered cells. Molecular Medicine Today. 41221-227.
   Google Scholar
• Mobley, H.L. and Haussinger, R. 1989. Microbial ureases : significance, regulation, and molecular characterisation. Microbiolo. Rev. 53( 1): 85-108.
   Google Scholar